摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2,4-二氨基-6-(4-氟苯基)嘧啶 | 175137-25-4

中文名称
2,4-二氨基-6-(4-氟苯基)嘧啶
中文别名
2,3-二甲基吡啶并[2,3-b]吡嗪-6(4H)-酮
英文名称
2,4-diamino-6-(4-fluorophenyl)-pyrimidine
英文别名
MayB2;6-(4-Fluorophenyl)pyrimidine-2,4-diamine
2,4-二氨基-6-(4-氟苯基)嘧啶化学式
CAS
175137-25-4
化学式
C10H9FN4
mdl
——
分子量
204.207
InChiKey
UJHDGCSPZQBXEB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    164 °C
  • 沸点:
    493.9±55.0 °C(Predicted)
  • 密度:
    1.361±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.3
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    77.8
  • 氢给体数:
    2
  • 氢受体数:
    5

安全信息

  • 危险品标志:
    Xi
  • 安全说明:
    S26,S36/37/39
  • 危险类别码:
    R36/37/38
  • 海关编码:
    2933599090

SDS

SDS:a4f3d43d8fa84ef79eb172bf03c1d183
查看

反应信息

  • 作为产物:
    描述:
    2,4-二氨基-6-氯嘧啶4-氟苯硼酸四(三苯基膦)钯 sodium carbonate 作用下, 以 乙二醇二甲醚 为溶剂, 以86%的产率得到2,4-二氨基-6-(4-氟苯基)嘧啶
    参考文献:
    名称:
    Synthesis of 6-aryl-2,4-diamino-pyrimidines and triazines using palladium catalysed Suzuki cross-coupling reactions
    摘要:
    The high yielding synthesis of 6-aryl-2,4-diaminopyrimidines and triazines via palladium catalysed Suzuki cross-coupling reactions of commercially available 6-chloro-2,4-diaminopyrimidine 1 or 6-chloro-2,4-diaminotriazine 8 and aryl boronic acids are described. (C) 2001 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0040-4020(01)00119-3
点击查看最新优质反应信息

文献信息

  • Ethylened polymer and molded object obtained therefrom
    申请人:Satoh Yasuo
    公开号:US20060135712A1
    公开(公告)日:2006-06-22
    An ethylene-based polymer which is an ethylene/C4 to C10 α-olefin copolymer and satisfies the following requirements [k1] to [k3]: [k1] melt flow rate (MFR) under a loading of 2.16 kg at 190° C. is in the range of 1.0 to 50 g/10 minutes; [k2] LNR defined as a scale of neck-in upon film molding is in the range of 0.6 to 1.4; and [k3] take-up speed at break [DS (m/min)] at 160° C. and melt flow rate (MFR) satisfy the following relationship (Eq-1): 12×MFR 0.577 ≦DS≦165×MFR 0.577 (Eq-1), and a thermoplastic resin composition containing the ethylene-based polymer, provide a molded product, preferably a film, excellent in moldability and mechanical strength. The ethylene-based polymer can be efficiently obtained by polymerization in the presence of an olefin polymerization catalyst formed from a solid carrier, (A) a solid transition metal catalyst component obtained by contacting (a) a compound of a transition metal of the group 4 in the periodic table, containing at least one ligand having a cyclopentadienyl skeleton, (b) an organoaluminum oxy compound, (c) a multifunctional organic halide, and if necessary (d) an organoaluminum compound, and if necessary (B) organoaluminum compound.
    一种乙烯基聚合物,它是一种乙烯/C4 至 C10 α-烯烃共聚物,并满足以下[k1]至[k3]的要求:[k1] 熔体流动速率(MFR)在 190 摄氏度、负载 2.16 千克的条件下,范围在 1.0 至 50 克/10 分钟之间;[k2] LNR 定义为薄膜成型时的缩颈比例,范围在 0.6 至 1.4 之间;以及 [k3] 160 摄氏度时的断裂收口速度[DS(米/分)]和熔体流动速率(MFR)满足以下关系式(公式-1):12×MFR 0.577 ≦DS≦165×MFR 0.577 (式-1),以及含有乙烯基聚合物的热塑性树脂组合物,可提供模塑产品,最好是薄膜,具有优异的模塑性和机械强度。乙烯基聚合物可通过在由固体载体、(A)固体过渡属催化剂组分、(B)有机铝氧化合物、(C)多功能有机卤化物和必要时(D)有机铝化合物以及必要时(B)有机铝化合物形成的烯烃聚合催化剂存在下进行聚合而有效地获得。
  • HEME OXYGENASE INHIBITORS, SCREENING METHODS FOR HEME OXYGENASE INHIBITORS AND METHODS OF USE OF HEME OXYGENASE INHIBITORS FOR ANTIMICROBIAL THERAPY
    申请人:Wilks Angela
    公开号:US20100081661A1
    公开(公告)日:2010-04-01
    Inhibitors of microbial heme oxygenase and their use for treatment of microbial infections and bioremediation. The inhibitors of microbial heme oxygenase are useful against a new class of antimicrobial agents to target infections that are persistently difficult to combat with the current spectrum of antimicrobial agents. Screening methods for selecting inhibitors of microbial heme oxygenase.
  • INHIBITOR OF HEME DEGRADATION FOR USE TO IMPROVE ANTIBIOTIC TREATMENT OF MYCOBACTERIUM TUBERCULOSIS INFECTION
    申请人:The United States of America, as represented by the Secretary, Department of Health and Human Serv
    公开号:US20190201414A1
    公开(公告)日:2019-07-04
    The present invention provides a method of preventing or treating a Mycobacterium tuberculosis (Mtb) infection in a mammal the method comprising administering to the mammal a first inhibitor, wherein the first inhibitor is an inhibitor of heme degradation and wherein the first inhibitor is a metal protoporphyrin, and administering to the mammal a second inhibitor, wherein the second inhibitor is an inhibitor of Mtb, wherein administration of the first and second inhibitors to the mammal prevents or treats Mtb infection in the mammal.
  • US7208559B2
    申请人:——
    公开号:US7208559B2
    公开(公告)日:2007-04-24
  • US8450368B2
    申请人:——
    公开号:US8450368B2
    公开(公告)日:2013-05-28
查看更多